Infosys Transforms NovaSom's Sleep Apnea Diagnostic Portal to Significantly Speed Test Result Processing
Poster: SySAdmin
Posted on January 14, 2013 at 8:21:01 AM
Infosys Transforms NovaSom's Sleep Apnea Diagnostic Portal to Significantly Speed Test Result Processing
BANGALORE, India and GLEN BURNIE, Maryland, January 14, 2013 /PRNewswire/ --
Cloud-based User Platform Expanded To Support New Offerings
Infosys [http://www.infosys.com/pages/index.aspx ], a global leader in consulting and
technology, has partnered with NovaSom, Inc. [http://www.novasom.com ], the leader in home
testing for obstructive sleep apnea (OSA), to significantly improve the efficiency of
administering and analyzing results of home tests.
Infosys has designed an innovative cloud-based user portal, Meditrack(R), on
Salesforce.com to broaden the reach and efficiency of NovaSom's diagnostic solution suite.
The new portal provides physicians with a single, easy-to-use interface that speeds up the
order-to-delivery of devices, processing of diagnostic data and management of insurance
claims.
Meditrack(R) provides Web interfaces with third-party applications to access and
analyze patient data immediately upon wireless receipt of the completed home sleep test.
The portal, launched earlier this year, enables NovaSom to shorten the time from test
completion to report generation by two days. This capability helps NovaSom's sleep
specialist customers deliver faster diagnoses to patients and speed their paths to
treatment.
"Patients with OSA are at an increased risk of other chronic diseases. The innovative
solution that we developed for NovaSom is helping OSA patients receive faster and better
medical care, said Dheeshjith V.G., Senior Vice President and Global Head, Life Sciences
at Infosys. "Leveraging our deep medical technology domain knowledge and harnessing the
latest technical advancements has allowed us to enable NovaSom to facilitate rapid
diagnostic and therapy cycles."
The NovaSom diagnostic solution also leverages AccuSom(R), the first and only
FDA-cleared wireless home sleep testing device. With more than 18 million moderate to
severe cases of OSA in the United States, NovaSom's suite of accurate, cost-effective home
sleep testing solutions is delivering new benefits to patients, health insurers, and
specialty and primary care physicians.
In 2012, NovaSom expanded its product suite, launching AccuSom Deliver(TM), a
customized turnkey solution allowing sleep specialists to incorporate high-quality,
at-home sleep testing into their practices on a larger scale. AccuSom Safe Recovery(TM)
was also launched this year, which leverages AccuSom's wireless functionality to complete
home sleep testing prior to surgery. The new portal from Infosys has helped NovaSom scale
operations to meet the expanded solution portfolio more effectively. Sleep specialists,
surgeons, and anesthesiologists can now develop a patient management plan that further
minimizes the risk of adverse respiratory events and other OSA-related complications
during and after surgery.
"A quicker OSA diagnosis is critical to helping sufferers get the therapy they need
sooner, and we are achieving that goal with the help of Infosys," said Richard Hassett,
MD, Chief Executive Officer, NovaSom. "The customized MediTrack portal enables us to
complete tests quickly and accurately. NovaSom's cloud-based infrastructure allows us to
partner with providers to improve access to care, reduce cost and address this undiagnosed
epidemic."
About NovaSom
NovaSom, Inc. is the market leader in obstructive sleep apnea home testing, with the
AccuSom Home Sleep Test, the first and only FDA-cleared wireless HST. The NovaSomhome
sleep testing technology and MediTrack portal have been shown to provide in-home,
clinically equivalent diagnosis of OSA at a significantly reduced cost as compared to
in-facility testing for uncomplicated, adult OSA. NovaSom's home sleep tests are currently
covered for more than 165 million Americans through partnerships with major health
insurers.
NovaSom also offers comprehensive service programs that are utilized by payers,
employers, primary care and sleep specialist physicians nationwide, that enable
significant cost savings for OSA management. In an effort to combat the growing OSA
epidemic, NovaSom also partners with sleep centers, enabling sleep specialists to offer
clinically appropriate patients an alternative, convenient testing option, expanding
access to diagnosis and treatment.
NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic
Center & Telehealth Provider and is approved by CMS as an Independent Diagnostic Testing
Facility. For more information, visit http://www.NovaSom.com.
About Infosys
Infosys partners with global enterprises to drive their innovation-led growth. That's
why Forbes ranked Infosys 19th among the top 100 most innovative companies. As a leading
provider of next-generation consulting, technology, and outsourcing solutions, Infosys
helps clients in more than 30 countries realize their goals. Visit http://www.infosys.com
[http://www.infosys.com/Pages/index.aspx ] and see how Infosys (NYSE: INFY), with its
150,000+ people, is Building Tomorrow's Enterprise(R) today.
Safe Harbor
Certain statements in this release concerning our future growth prospects are
forward-looking statements, which involve a number of risks and uncertainties that could
cause actual results to differ materially from those in such forward-looking statements.
The risks and uncertainties relating to these statements include, but are not limited to,
risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign
exchange rates, our ability to manage growth, intense competition in IT services including
those factors which may affect our cost advantage, wage increases in India, our ability to
attract and retain highly skilled professionals, time and cost overruns on fixed-price,
fixed-time frame contracts, client concentration, restrictions on immigration, industry
segment concentration, our ability to manage our international operations, reduced demand
for technology in our key focus areas, disruptions in telecommunication networks or system
failures, our ability to successfully complete and integrate potential acquisitions,
liability for damages on our service contracts, the success of the companies in which
Infosys has made strategic investments, withdrawal or expiration of governmental fiscal
incentives, political instability and regional conflicts, legal restrictions on raising
capital or acquiring companies outside India, and unauthorized use of our intellectual
property and general economic conditions affecting our industry. Additional risks that
could affect our future operating results are more fully described in our United States
Securities and Exchange Commission filings including our Annual Report on Form 20-F for
the fiscal year ended March 31, 2012 and on Form 6-K for the quarters ended December 31,
2011, June 30, 2012 and September 30, 2012.These filings are available at
http://www.sec.gov. Infosys may, from time to time, make additional written and oral
forward-looking statements, including statements contained in the company's filings with
the Securities and Exchange Commission and our reports to shareholders. The company does
not undertake to update any forward-looking statements that may be made from time to time
by or on behalf of the company.
For Further information please contact:
Asia Pacific
Abhijith Karthikeya D
Infosys, India
Phone: +91-80-41563373
Abhijith_Damodar@infosys.com
The Americas
Jay Barta
Infosys, US
Phone: +1-510-926-7840
Jay_Barta@Infosys.com
Isabel Portieles
NovaSom, Inc.
Phone: +1-410-590-0443
iportieles@NovaSom.com
Infosys
BANGALORE, India and GLEN BURNIE, Maryland, January 14, 2013 /PRNewswire/ --
Cloud-based User Platform Expanded To Support New Offerings
Infosys [http://www.infosys.com/pages/index.aspx ], a global leader in consulting and
technology, has partnered with NovaSom, Inc. [http://www.novasom.com ], the leader in home
testing for obstructive sleep apnea (OSA), to significantly improve the efficiency of
administering and analyzing results of home tests.
Infosys has designed an innovative cloud-based user portal, Meditrack(R), on
Salesforce.com to broaden the reach and efficiency of NovaSom's diagnostic solution suite.
The new portal provides physicians with a single, easy-to-use interface that speeds up the
order-to-delivery of devices, processing of diagnostic data and management of insurance
claims.
Meditrack(R) provides Web interfaces with third-party applications to access and
analyze patient data immediately upon wireless receipt of the completed home sleep test.
The portal, launched earlier this year, enables NovaSom to shorten the time from test
completion to report generation by two days. This capability helps NovaSom's sleep
specialist customers deliver faster diagnoses to patients and speed their paths to
treatment.
"Patients with OSA are at an increased risk of other chronic diseases. The innovative
solution that we developed for NovaSom is helping OSA patients receive faster and better
medical care, said Dheeshjith V.G., Senior Vice President and Global Head, Life Sciences
at Infosys. "Leveraging our deep medical technology domain knowledge and harnessing the
latest technical advancements has allowed us to enable NovaSom to facilitate rapid
diagnostic and therapy cycles."
The NovaSom diagnostic solution also leverages AccuSom(R), the first and only
FDA-cleared wireless home sleep testing device. With more than 18 million moderate to
severe cases of OSA in the United States, NovaSom's suite of accurate, cost-effective home
sleep testing solutions is delivering new benefits to patients, health insurers, and
specialty and primary care physicians.
In 2012, NovaSom expanded its product suite, launching AccuSom Deliver(TM), a
customized turnkey solution allowing sleep specialists to incorporate high-quality,
at-home sleep testing into their practices on a larger scale. AccuSom Safe Recovery(TM)
was also launched this year, which leverages AccuSom's wireless functionality to complete
home sleep testing prior to surgery. The new portal from Infosys has helped NovaSom scale
operations to meet the expanded solution portfolio more effectively. Sleep specialists,
surgeons, and anesthesiologists can now develop a patient management plan that further
minimizes the risk of adverse respiratory events and other OSA-related complications
during and after surgery.
"A quicker OSA diagnosis is critical to helping sufferers get the therapy they need
sooner, and we are achieving that goal with the help of Infosys," said Richard Hassett,
MD, Chief Executive Officer, NovaSom. "The customized MediTrack portal enables us to
complete tests quickly and accurately. NovaSom's cloud-based infrastructure allows us to
partner with providers to improve access to care, reduce cost and address this undiagnosed
epidemic."
About NovaSom
NovaSom, Inc. is the market leader in obstructive sleep apnea home testing, with the
AccuSom Home Sleep Test, the first and only FDA-cleared wireless HST. The NovaSomhome
sleep testing technology and MediTrack portal have been shown to provide in-home,
clinically equivalent diagnosis of OSA at a significantly reduced cost as compared to
in-facility testing for uncomplicated, adult OSA. NovaSom's home sleep tests are currently
covered for more than 165 million Americans through partnerships with major health
insurers.
NovaSom also offers comprehensive service programs that are utilized by payers,
employers, primary care and sleep specialist physicians nationwide, that enable
significant cost savings for OSA management. In an effort to combat the growing OSA
epidemic, NovaSom also partners with sleep centers, enabling sleep specialists to offer
clinically appropriate patients an alternative, convenient testing option, expanding
access to diagnosis and treatment.
NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic
Center & Telehealth Provider and is approved by CMS as an Independent Diagnostic Testing
Facility. For more information, visit http://www.NovaSom.com.
About Infosys
Infosys partners with global enterprises to drive their innovation-led growth. That's
why Forbes ranked Infosys 19th among the top 100 most innovative companies. As a leading
provider of next-generation consulting, technology, and outsourcing solutions, Infosys
helps clients in more than 30 countries realize their goals. Visit http://www.infosys.com
[http://www.infosys.com/Pages/index.aspx ] and see how Infosys (NYSE: INFY), with its
150,000+ people, is Building Tomorrow's Enterprise(R) today.
Safe Harbor
Certain statements in this release concerning our future growth prospects are
forward-looking statements, which involve a number of risks and uncertainties that could
cause actual results to differ materially from those in such forward-looking statements.
The risks and uncertainties relating to these statements include, but are not limited to,
risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign
exchange rates, our ability to manage growth, intense competition in IT services including
those factors which may affect our cost advantage, wage increases in India, our ability to
attract and retain highly skilled professionals, time and cost overruns on fixed-price,
fixed-time frame contracts, client concentration, restrictions on immigration, industry
segment concentration, our ability to manage our international operations, reduced demand
for technology in our key focus areas, disruptions in telecommunication networks or system
failures, our ability to successfully complete and integrate potential acquisitions,
liability for damages on our service contracts, the success of the companies in which
Infosys has made strategic investments, withdrawal or expiration of governmental fiscal
incentives, political instability and regional conflicts, legal restrictions on raising
capital or acquiring companies outside India, and unauthorized use of our intellectual
property and general economic conditions affecting our industry. Additional risks that
could affect our future operating results are more fully described in our United States
Securities and Exchange Commission filings including our Annual Report on Form 20-F for
the fiscal year ended March 31, 2012 and on Form 6-K for the quarters ended December 31,
2011, June 30, 2012 and September 30, 2012.These filings are available at
http://www.sec.gov. Infosys may, from time to time, make additional written and oral
forward-looking statements, including statements contained in the company's filings with
the Securities and Exchange Commission and our reports to shareholders. The company does
not undertake to update any forward-looking statements that may be made from time to time
by or on behalf of the company.
For Further information please contact:
Asia Pacific
Abhijith Karthikeya D
Infosys, India
Phone: +91-80-41563373
Abhijith_Damodar@infosys.com
The Americas
Jay Barta
Infosys, US
Phone: +1-510-926-7840
Jay_Barta@Infosys.com
Isabel Portieles
NovaSom, Inc.
Phone: +1-410-590-0443
iportieles@NovaSom.com
Infosys